Embecta Corp. (EMBC) — Stock Valuation & Research

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in…

EMBC key statistics

Price$5.26
Market cap$312.06M
SectorHealthcare
IndustryMedical - Instruments & Supplies
ExchangeNASDAQ
52-week range2.77-15.17
Dividend (TTM)$0.32 per share
Beta0.85

Explore EMBC's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.